Compugen, Ltd.
Drug and diagnostic discovery company provides Q3 update; revenues dip
Published in Genetics and Environmental Business Week, December 2nd, 2004
These results reflect the implementation of the company's previously announced decision to focus on diagnostic and therapeutic discovery and related intellectual property-based commercialization and alliances. As part of this ongoing implementation, the company has discontinued the marketing of certain software tools and other products.
"During the past quarter, we signed our first diagnostic pipeline agreement with Diagnostic Products Corp. (DP), and published our findings with respect to RNA...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Genetics and Environmental Business Week
More Articles from Genetics and Environmental Business Week
- Celera Genomics Group
Genomics company reports loss of $0.28 per share - Collaborations
Sales, development agreement signed for treatment planning software - Electro-Optical Sciences, Inc
Vision technology firm raises $9M, obtains protocol agreement for MelaFind - Kos Pharmaceuticals, Inc.
Pharmaceutical company reports third quarter results - Medical Staffing Network Holdings, Inc.
Medical staffing company announces financial results - NimbleGen Systems Inc.
Gene expression company announces closing of series F financing - More from this issue of Genetics and Environmental Business Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
